Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Commercialisation of Ayush Drugs, Technologies: New policy calls for 4 percent royalty to CCRAS

      Commercialisation of Ayush Drugs, Technologies: New policy calls for 4 percent royalty to CCRAS

      Garima16 Jan 2019 5:20 PM IST
      The policy focuses on the commercialisation of the various AYUSH drugs, Processes, Instrumentation that is developed by CCRAS. The various...
      Zydus Cadila gets USFDA nod for generic cholesterol drug

      Zydus Cadila gets USFDA nod for generic cholesterol drug

      Garima23 Nov 2018 12:15 PM IST
      New Delhi: Drug maker Zydus Cadila Thursday said it has received approval from the US health regulator to market cholesterol-lowering drug...
      Manipal eyes Medanta, Sets Valuation at Rs 6000 crore: Report

      Manipal eyes Medanta, Sets Valuation at Rs 6000 crore: Report

      Garima25 Oct 2018 5:47 PM IST
      Mumbai: After facing a setback with the lost Fortis bid, the healthcare giant, TPG Capital and Manipal Health Enterprises combine, is leaving no stone...
      Lupin gets USFDA nod to market antipsychotic drug

      Lupin gets USFDA nod to market antipsychotic drug

      Garima16 Oct 2018 9:16 AM IST
      New Delhi: Drug firm Lupin Monday said it has received tentative nod from the US health regulator to market its antipsychotic Lurasidone Hydrochloride...
      Union Health Ministry Lifts BAN on Oxytocin Retail, Regulations Imposed

      Union Health Ministry Lifts BAN on Oxytocin Retail, Regulations Imposed

      Garima23 Aug 2018 5:32 PM IST
      New Delhi: The ‘Oxytocin Ban’, that followed complaints of rampant misuse of the drug, has finally been lifted by the Union Health Ministry, but...
      Lupin launches Clobetasol Propionate Skin cream in US

      Lupin launches Clobetasol Propionate Skin cream in US

      Garima23 Aug 2018 1:18 PM IST
      Clobetasol Propionate cream is "indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatosesNew Delhi:...
      Pfizer, Astellas to Change Xtandis Trial Protocols to Speed Up Results

      Pfizer, Astellas to Change Xtandi's Trial Protocols to Speed Up Results

      Garima23 Aug 2018 10:00 AM IST
      New Delhi: Drugmakers Pfizer Inc and Astellas Pharma Inc recently stated that they would change protocols for two late-stage trials testing prostate...
      Lupin gets USFDA approval for Mild Atopic dermatitis treatment lotion

      Lupin gets USFDA approval for Mild Atopic dermatitis treatment lotion

      Garima23 Aug 2018 9:30 AM IST
      New Delhi: Drug major Lupin recently stated it has received final approval from the United States Food and Drug Administration (USFDA) to market...
      Wasazra plans to Expand PAN India

      Wasazra plans to Expand PAN India

      Garima23 Aug 2018 9:00 AM IST
      Lucknow: Last year has gone extremely well for Wasazra, in just one year, the company registered as public limited and has been instrumental in...
      Prev

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok